XML 69 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
FAIR VALUE MEASUREMENTS
12 Months Ended
Dec. 31, 2013
FAIR VALUE MEASUREMENTS  
FAIR VALUE MEASUREMENTS

NOTE 11—FAIR VALUE MEASUREMENTS

         The Company measures certain financial assets and liabilities at fair value on a recurring basis in the financial statements. The hierarchy ranks the quality and reliability of inputs, or assumptions, used in the determination of fair value and requires financial assets and liabilities carried at fair value to be classified and disclosed in one of the following three categories:

  • Level 1—quoted prices in active markets for identical assets and liabilities;

    Level 2—unadjusted quoted prices in active markets for similar assets or liabilities, or unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that observable for the asset or liability; and

    Level 3—unobservable inputs that are not corroborated by market data.

         The following table provides the fair value measurements of applicable financial assets and liabilities as of December 31, 2013:

 
  Financial assets and
liabilities
at fair value as of
December 31, 2013
 
 
  Level 1   Level 2   Level 3  

Money market funds(1)

  $ 29,458   $   $  

Deferred compensation(2)

  $   $ 830   $  
               

Total

  $ 29,458   $ 830   $  
               
               

         The following table provides the fair value measurements of applicable financial assets and liabilities as of December 31, 2012:

 
  Financial assets and liabilities
at fair value as of
December 31, 2012
 
 
  Level 1   Level 2   Level 3  

Money market funds(1)

  $ 24,448   $   $  

Deferred compensation(2)

  $   $ 1,165   $  
               

Total

  $ 24,448   $ 1,165   $  
               
               

(1)
Included in cash and cash equivalents on the Company's Consolidated Balance Sheets. The carrying amount of money market funds is a reasonable estimate of fair value.

(2)
Included in other long-term liabilities on the Company's Consolidated Balance Sheets. Refer to Note 15 for further information.